COVID-19 Response

Research Themes:

How HE2RO is responding to the COVID-19 virus:

South Africa has the highest number of HIV cases in the world with a substantial cohort of TB cases. The emergence of COVID-19 in South Africa is likely to have a disproportionate impact on our vulnerable HIV and TB populations, particularly in those who are not virally suppressed or not on ART. TB patients will be especially vulnerable with the impact the coronavirus has on lung function. Current data shows that the rate of serious infection and mortality from COVID-19 is highest in older populations with pre-existing co-morbidities. In South Africa, we urgently need to provide modeling and costing data to inform the response to COVID-19 and the impact of prevention and mitigation as well as timeous resource allocation.

At HE2RO, we have allocated a portion of our EVIDENCE funding towards modeling and costing the NDoH response to the COVID-19 crisis that our country is currently facing as well as assisting with contributing towards developing and populating a predictive model on COVID-19 that will take into account the impact on HIV and TB as well as estimating resource allocation and budget impact at a national and provincial level.


Principal Investigator/ Program Director Jacqui Miot
Start dateMarch 2020
End date

Funded by


HE2RO staff involved

Stay up to date

Receive newsletters and keep up to date with developments at HE2RO.